ArticleMedical oncology (Northwood, London, England)2021

Detection of mutations in CML patients resistant to tyrosine kinase inhibitor: imatinib mesylate therapy.

Nilgun Karasu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.